本页面由Tiger Trade Technology Pte. Ltd.提供服务

Atea Pharmaceuticals, Inc.

3.15
-0.0400-1.25%
盘后3.150.00000.00%16:10 EST
成交量:23.28万
成交额:73.83万
市值:2.46亿
市盈率:-1.78
高:3.23
开:3.19
低:3.14
收:3.19
52周最高:4.02
52周最低:2.46
股本:7,812.68万
流通股本:6,000.97万
量比:0.74
换手率:0.39%
股息:- -
股息率:- -
每股收益(TTM):-1.7696
每股收益(LYR):-1.9983
净资产收益率:-37.98%
总资产收益率:-23.86%
市净率:0.78
市盈率(LYR):-1.58

数据加载中...

2021/04/19

重要事件披露

8-K - Current report
2021/04/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/30

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/12

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/11/05

重要事件披露

8-K - Current report
2020/10/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/10/29

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/27

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/27

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/26

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/23

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/10/09

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933